Evidence map›Paper›PMID 30719164›Full record

ArticleJournal of Cancer2019

Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma.

Yong Le, Jing-Xian Shen, Yong-Fa Zhang, Min-Ke He, Anna Kan, Hai-Long Chen, Zi-Shan Yu, Qi-Jiong Li, Ming Shi

Abstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yong LeDepartment of Hepatobiliary Oncology, Cancer Centre, Sun Yat-sen University, Guangzhou, China.
Jing-Xian ShenCollaborative Innovation Centre for Cancer Medicine, Cancer Centre, Sun Yat-sen University, Guangzhou, China.
Yong-Fa ZhangDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Min-Ke HeDepartment of Hepatobiliary Oncology, Cancer Centre, Sun Yat-sen University, Guangzhou, China.
Anna KanCollaborative Innovation Centre for Cancer Medicine, Cancer Centre, Sun Yat-sen University, Guangzhou, China.
Hai-Long ChenCollaborative Innovation Centre for Cancer Medicine, Cancer Centre, Sun Yat-sen University, Guangzhou, China.
Zi-Shan YuDepartment of Hepatobiliary Oncology, Cancer Centre, Sun Yat-sen University, Guangzhou, China.
Qi-Jiong LiDepartment of Hepatobiliary Oncology, Cancer Centre, Sun Yat-sen University, Guangzhou, China.
Ming ShiDepartment of Hepatobiliary Oncology, Cancer Centre, Sun Yat-sen University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Advanced hepatocellularPrognosisTransarterial chemoembolization

Identifiers

PMID30719164
PMCPMC6360434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.